The Discounted Cash Flow (DCF) valuation of Acura Pharmaceuticals Inc (ACUR) is (0.47) USD. With the latest stock price at 0.02 USD, the upside of Acura Pharmaceuticals Inc based on DCF is -2443.3%.
Based on the latest price of 0.02 USD and our DCF valuation, Acura Pharmaceuticals Inc (ACUR) is a sell. selling ACUR stocks now will result in a potential gain of 2443.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.5% - 5.2% | 4.9% |
| Long-term Growth Rate | 2.5% - 4.3% | 3.4% |
| Fair Price | (2.69) - (0.27) | (0.47) |
| Upside | -13544.8% - -1429.8% | -2443.3% |